Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nuvalent, Inc. (NUVL) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nuvalent, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1861560.
Total stock buying since 2021: $34,270,000.
Total stock sales since 2021: $506,562,628.
Total stock option exercises since 2021: $20,817,339.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 681,254 | $54,090,684 | 648,440 | $13,047,258 |
| 2024 | 0 | $0 | 4,713,129 | $416,846,343 | 305,448 | $5,726,848 |
| 2023 | 0 | $0 | 481,138 | $29,610,739 | 261,138 | $1,884,101 |
| 2022 | 650,000 | $21,775,000 | 227,400 | $6,014,862 | 58,513 | $159,132 |
| 2021 | 735,000 | $12,495,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-18 | Miller Deborah Ann (Chief Legal Officer) | Sale | 33,046 | 75.82 | 2,505,547 |
| 2023-12-18 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 33,046 | 27.85 | 920,331 |
| 2023-12-18 | Noci Darlene (Chief Development Officer) | Sale | 40,000 | 75.82 | 3,032,799 |
| 2023-12-18 | Noci Darlene (Chief Development Officer) | Option Ex | 40,000 | 7.46 | 298,280 |
| 2023-12-18 | Balcom Alexandra (Chief Financial Officer) | Sale | 30,000 | 75.82 | 2,274,600 |
| 2023-12-18 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 30,000 | 1.08 | 32,400 |
| 2023-12-18 | Protopapas Anna (Director) | Sale | 5,000 | 75.67 | 378,350 |
| 2023-12-18 | Protopapas Anna (Director) | Option Ex | 5,000 | 9.36 | 46,800 |
| 2023-11-28 | Shair Matthew (Director) | Sale | 9,150 | 62.02 | 567,528 |
| 2023-11-01 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 52.31 | 156,939 |
| 2023-11-01 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-10-24 | Shair Matthew (Director) | Sale | 91,700 | 50.93 | 4,670,281 |
| 2023-10-04 | Noci Darlene (Chief Development Officer) | Sale | 20,000 | 56.48 | 1,129,500 |
| 2023-10-04 | Noci Darlene (Chief Development Officer) | Option Ex | 20,000 | 3.98 | 79,700 |
| 2023-10-04 | Turner Christopher Durant (Chief Medical Officer) | Sale | 7,995 | 55.01 | 439,804 |
| 2023-10-04 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 7,995 | 6.89 | 55,085 |
| 2023-10-02 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 46.12 | 138,369 |
| 2023-10-02 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-09-15 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 47.71 | 95,420 |
| 2023-09-15 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2023-09-01 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 46.49 | 139,470 |
| 2023-09-01 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-08-01 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 49.88 | 149,640 |
| 2023-08-01 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-07-31 | Balcom Alexandra (Chief Financial Officer) | Sale | 25,000 | 49.05 | 1,226,250 |
| 2023-07-31 | Balcom Alexandra (Chief Financial Officer) | Option Ex | 25,000 | 1.08 | 27,000 |
| 2023-07-28 | Miller Deborah Ann (Chief Legal Officer) | Sale | 6,500 | 48.52 | 315,380 |
| 2023-07-28 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 6,500 | 6.89 | 44,785 |
| 2023-07-28 | Turner Christopher Durant (Chief Medical Officer) | Sale | 2,665 | 48.93 | 130,398 |
| 2023-07-28 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 2,665 | 6.89 | 18,361 |
| 2023-07-26 | Turner Christopher Durant (Chief Medical Officer) | Sale | 2,365 | 46.85 | 110,800 |
| 2023-07-26 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 2,365 | 6.89 | 16,294 |
| 2023-07-24 | Turner Christopher Durant (Chief Medical Officer) | Sale | 200 | 46.82 | 9,364 |
| 2023-07-24 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 200 | 6.89 | 1,378 |
| 2023-07-20 | Noci Darlene (Chief Development Officer) | Sale | 10,941 | 45.17 | 494,204 |
| 2023-07-20 | Noci Darlene (Chief Development Officer) | Option Ex | 10,941 | 1.08 | 11,816 |
| 2023-07-20 | Turner Christopher Durant (Chief Medical Officer) | Sale | 100 | 46.80 | 4,680 |
| 2023-07-20 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 100 | 6.89 | 689 |
| 2023-07-19 | Noci Darlene (Chief Development Officer) | Sale | 4,559 | 45.04 | 205,337 |
| 2023-07-19 | Noci Darlene (Chief Development Officer) | Option Ex | 4,559 | 1.08 | 4,923 |
| 2023-07-17 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 42.74 | 85,474 |
| 2023-07-17 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2023-07-03 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 41.73 | 125,175 |
| 2023-07-03 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-06-16 | Noci Darlene (Chief Development Officer) | Sale | 2,900 | 45.19 | 131,051 |
| 2023-06-16 | Noci Darlene (Chief Development Officer) | Option Ex | 2,900 | 1.08 | 3,132 |
| 2023-06-15 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 44.05 | 88,094 |
| 2023-06-15 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2023-06-15 | Noci Darlene (Chief Development Officer) | Sale | 1,000 | 45.07 | 45,070 |
| 2023-06-15 | Noci Darlene (Chief Development Officer) | Option Ex | 1,000 | 1.08 | 1,080 |
| 2023-06-05 | Noci Darlene (Chief Development Officer) | Sale | 600 | 45.00 | 27,000 |
| 2023-06-05 | Noci Darlene (Chief Development Officer) | Option Ex | 600 | 1.08 | 648 |
| 2023-06-05 | Turner Christopher Durant (Chief Medical Officer) | Sale | 10,235 | 44.86 | 459,142 |
| 2023-06-05 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 10,235 | 6.89 | 70,519 |
| 2023-06-01 | Noci Darlene (Chief Development Officer) | Sale | 6,000 | 42.32 | 253,902 |
| 2023-06-01 | Noci Darlene (Chief Development Officer) | Option Ex | 6,000 | 1.08 | 6,480 |
| 2023-05-15 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 40.60 | 81,200 |
| 2023-05-15 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2023-05-09 | Miller Deborah Ann (Chief Legal Officer) | Sale | 1,332 | 39.63 | 52,787 |
| 2023-05-09 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 1,332 | 6.89 | 9,177 |
| 2023-05-05 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,800 | 39.64 | 110,992 |
| 2023-05-05 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,800 | 6.89 | 19,292 |
| 2023-05-01 | Miller Deborah Ann (Chief Legal Officer) | Sale | 900 | 39.61 | 35,649 |
| 2023-05-01 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 900 | 6.89 | 6,201 |
| 2023-05-01 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 37.82 | 113,466 |
| 2023-05-01 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-04-17 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 29.74 | 59,480 |
| 2023-04-17 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2023-04-03 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 26.82 | 80,445 |
| 2023-04-03 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-03-01 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 30.08 | 90,240 |
| 2023-03-01 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2023-02-15 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 29.85 | 59,700 |
| 2023-02-15 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2023-02-02 | Noci Darlene (Chief Development Officer) | Sale | 3,000 | 29.64 | 88,935 |
| 2023-02-02 | Noci Darlene (Chief Development Officer) | Option Ex | 3,000 | 1.08 | 3,240 |
| 2022-11-15 | Miller Deborah Ann (Chief Legal Officer) | Sale | 2,000 | 32.02 | 64,034 |
| 2022-11-15 | Miller Deborah Ann (Chief Legal Officer) | Option Ex | 2,000 | 6.89 | 13,780 |
| 2022-11-15 | Noci Darlene (Chief Development Officer) | Sale | 4,200 | 31.90 | 133,980 |
| 2022-11-15 | Noci Darlene (Chief Development Officer) | Option Ex | 4,200 | 1.08 | 4,536 |
| 2022-11-03 | Shair Matthew (Director) | Sale | 37,939 | 29.77 | 1,129,557 |
| 2022-11-03 | Deerfield Private Design Fund Iv, L.p. | Buy | 650,000 | 33.50 | 21,775,000 |
| 2022-11-02 | Shair Matthew (Director) | Sale | 95,455 | 32.15 | 3,068,400 |
| 2022-10-14 | Noci Darlene (Chief Development Officer) | Sale | 4,200 | 21.41 | 89,922 |
| 2022-10-14 | Noci Darlene (Chief Development Officer) | Option Ex | 4,200 | 1.08 | 4,536 |
| 2022-10-07 | Shair Matthew (Director) | Sale | 12,613 | 19.09 | 240,719 |
| 2022-10-06 | Shair Matthew (Director) | Sale | 8,608 | 19.00 | 163,552 |
| 2022-10-05 | Shair Matthew (Director) | Sale | 7,884 | 19.22 | 151,530 |
| 2022-09-15 | Noci Darlene (Chief Development Officer) | Sale | 4,200 | 18.14 | 76,188 |
| 2022-09-15 | Noci Darlene (Chief Development Officer) | Option Ex | 4,200 | 1.08 | 4,536 |
| 2022-09-15 | Shair Matthew (Director) | Sale | 5,650 | 18.34 | 103,621 |
| 2022-09-14 | Shair Matthew (Director) | Sale | 13,151 | 18.36 | 241,452 |
| 2022-08-24 | Noci Darlene (Chief Development Officer) | Sale | 1,604 | 17.03 | 27,316 |
| 2022-08-24 | Noci Darlene (Chief Development Officer) | Option Ex | 1,604 | 1.08 | 1,732 |
| 2022-08-15 | Noci Darlene (Chief Development Officer) | Sale | 2,596 | 17.02 | 44,183 |
| 2022-08-15 | Noci Darlene (Chief Development Officer) | Option Ex | 2,596 | 1.08 | 2,803 |
| 2022-07-19 | Noci Darlene (Chief Development Officer) | Sale | 318 | 17.02 | 5,412 |
| 2022-07-19 | Noci Darlene (Chief Development Officer) | Option Ex | 318 | 1.08 | 343 |
| 2022-07-18 | Noci Darlene (Chief Development Officer) | Sale | 100 | 17.07 | 1,707 |
| 2022-07-18 | Noci Darlene (Chief Development Officer) | Option Ex | 100 | 1.08 | 108 |
| 2022-07-15 | Noci Darlene (Chief Development Officer) | Sale | 3,782 | 17.70 | 66,922 |
| 2022-07-15 | Noci Darlene (Chief Development Officer) | Option Ex | 3,782 | 1.08 | 4,084 |
| 2022-07-15 | Shair Matthew (Director) | Sale | 2,000 | 18.29 | 36,580 |
| 2022-07-13 | Shair Matthew (Director) | Sale | 100 | 18.25 | 1,825 |
| 2022-07-07 | Noci Darlene (See Remarks) | Sale | 16,800 | 17.61 | 295,848 |
| 2022-07-07 | Noci Darlene (See Remarks) | Option Ex | 16,800 | 1.08 | 18,144 |
| 2022-05-17 | Turner Christopher Durant (Chief Medical Officer) | Option Ex | 14,513 | 6.89 | 99,994 |
| 2022-02-15 | Noci Darlene (See Remarks) | Sale | 4,200 | 17.17 | 72,114 |
| 2022-02-15 | Noci Darlene (See Remarks) | Option Ex | 4,200 | 1.08 | 4,536 |
| 2021-08-02 | Hack Andrew A. F. (Director) | Buy | 735,000 | 17.00 | 12,495,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NUVL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nuvalent, Inc. (symbol NUVL, CIK number 1861560) see the Securities and Exchange Commission (SEC) website.